Skip to content
OpenCapital
Get started

Orchestra BioMed Holdings, Inc. OBIO Q3 2025 earnings

Reported November 10, 2025 · Before market open

Revenue$861.0KBeat by $119.6K
EPS-$0.40Miss by $0.02
Revenue estimate$741.4K
EPS estimate-$0.38

Next report

Aug 11, 2026 (In 1 week)
Revenue estimate$137.7K
EPS estimate-$0.39

Versus estimates

Revenue

Q1 2026$110.0KMiss by $808.7KQ4 2025$30.9MBeat by $30.0M
Q3 2025$861.0KBeat by $119.6K
Q2 2025$836.0KBeat by $57.2KQ1 2025$253.0KMiss by $269.3KQ4 2024$253.0K

Diluted EPS

Q1 2026-$0.33Beat by $0.07Q4 2025$0.26Beat by $0.64
Q3 2025-$0.40Miss by $0.02
Q2 2025-$0.50Beat by $0.01Q1 2025-$0.43In lineQ4 2024-$0.37Beat by $0.06

Ask the moment Orchestra BioMed Holdings, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Orchestra BioMed Holdings, Inc. report Q3 2025 earnings?
Orchestra BioMed Holdings, Inc. (OBIO) reported Q3 2025 earnings on November 10, 2025 before market open.
What were Orchestra BioMed Holdings, Inc.'s Q3 2025 revenue and EPS?
Orchestra BioMed Holdings, Inc. reported revenue of $861.0K and eps of $-0.40 for Q3 2025.
Did Orchestra BioMed Holdings, Inc. beat estimates in Q3 2025?
Revenue beat the consensus estimate of $741.4K by $119.6K. EPS missed the consensus estimate of $-0.38 by $0.02.
How did Orchestra BioMed Holdings, Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 12.8% from $987.0K a year earlier and eps grew 2.4% from $-0.41.
Where can I find Orchestra BioMed Holdings, Inc.'s Q3 2025 SEC filings?
You can read the 10-Q periodic report (0001104659-25-109128) directly on SEC EDGAR. The filing index links above go to sec.gov.